Clinical Orthopaedics and Related Research®
© The Association of Bone and Joint Surgeons® 2010
10.1007/s11999-010-1270-3

Erratum

Erratum to: One Intraoperative Dose of Tranexamic Acid for Patients Having Primary Hip or Knee Arthroplasty

Fiona E. Ralley1, Donna Berta2, Valerie Binns2, James Howard3 and Douglas D. R. Naudie3 Contact Information

(1)  Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London, ON, Canada
(2)  Ontario Transfusion Coordinators (ONTraC), London, ON, Canada
(3)  Division of Orthopaedic Surgery, London Health Sciences Center, University Hospital, 339 Windermere Road, London, ON, N6A 5A5, Canada

Contact Information Douglas D. R. Naudie
Email: Douglas.Naudie@lhsc.on.ca

Published online: 9 March 2010

Without Abstract
(Ralley FE, Berta D, Binns V, Howard J, Naudie DDR. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2009 Jan 9. [Epub ahead of print]).
The online version of the original article can be found under doi:10.1007/s11999-009-1217-8.
Erratum to: Clin Orthop Relat Res DOI 10.1007/s11999-009-1217-8

It has been brought to our attention by one of the online readers that there is an error in the Abstract and Results sections of our manuscript. We meant to say that the decrease in hemoglobin was less in 2008 than in 2007—as shown by the data in Table 2 and hence indicating, as the Discussion correctly points out, that the TEA protocol seems to reduce the perioperative decrease in hemoglobin when compared with a similar cohort of patients who did not receive TEA.

The first sentence in the Results section of the Abstract currently states: We found a reduction in the decrease in hemoglobin in 2007 compared with 2008 for THA and TKA (46 to 39 g/L and 45 to 36 g/L, respectively), which led to a reduction in transfusion rates (13.5% to 3.6% and 13.1% to 2.0%, respectively and higher hemoglobin levels at discharge.

The first sentence in the Results section of the Abstract should be: We found a reduction in the decrease in hemoglobin in 2008 compared with 2007 for THA and TKA (39 from 46 g/L and 36 from 45 g/L, respectively), which led to a reduction in transfusion rates (3.6% from 13.5% and 2.0% from 13.4%, respectively) and higher hemoglobin levels at discharge.

The first sentence in the Results section of the manuscript currently states: The decrease in hemoglobin was less in 2007 than in 2008 for patients who had THAs and TKAs (46 to 39 g/L [p < 0.001] and 45 to 36 g/L [p < 0.001] respectively) (Table 2).

The first sentence in the Results section of the manuscript should be: The decrease in hemoglobin was less in 2008 than in 2007 for patients who had THAs and TKAs (39 from 46 g/L [p < 0.001] and 36 from 45 g/L [p < 0.001], respectively) (Table 2).

We apologize for this error.